TAF-containing and TAF-independent forms of transcriptionally active TBP in vivo

Science

Volumn 288, Issue 5469, 2000, Pages 1244-1248

  Kuras, Laurent ^a   Kosa, Peter ^a   Mencia, Mario ^a   Struhl, Kevin ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TATA BINDING PROTEIN;

ARTICLE; FUNGAL GENETICS; GENE ACTIVITY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; PRIORITY JOURNAL; PROMOTER REGION;

ACETYLTRANSFERASES; DNA POLYMERASE II; DNA-BINDING PROTEINS; FUNGAL PROTEINS; HEAT-SHOCK PROTEINS; HISTONE ACETYLTRANSFERASES; PROMOTER REGIONS (GENETICS); SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; TATA BOX; TATA-BOX BINDING PROTEIN; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR TFIIA; TRANSCRIPTION FACTOR TFIIB; TRANSCRIPTION FACTOR TFIID; TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS, TFII;

EID: 0034686037     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.288.5469.1244     Document Type: Article

References (38)

1. S. K. Burley and R. G. Roeder, Annu. Rev. Biochem. 65, 769 (1996); C. P. Verrijzer and R. Tjian, Trends Biochem. Sci. 21, 338 (1996); K. Struhl and Z. Moqtaderi, Cell 94, 1 (1998).
2. S. K. Burley and R. G. Roeder, Annu. Rev. Biochem. 65, 769 (1996); C. P. Verrijzer and R. Tjian, Trends Biochem. Sci. 21, 338 (1996); K. Struhl and Z. Moqtaderi, Cell 94, 1 (1998).
3. S. K. Burley and R. G. Roeder, Annu. Rev. Biochem. 65, 769 (1996); C. P. Verrijzer and R. Tjian, Trends Biochem. Sci. 21, 338 (1996); K. Struhl and Z. Moqtaderi, Cell 94, 1 (1998).
4. D. B. Nikolov et al., Nature 377, 119 (1995); J. H. Geiger, S. Hahn, S. Lee, P. B. Sigler, Science 272, 830 (1996); S. Tan, Y. Hunziker, D. F. Sargent, T. J. Richmond, Nature 381, 127 (1996).
5. D. B. Nikolov et al., Nature 377, 119 (1995); J. H. Geiger, S. Hahn, S. Lee, P. B. Sigler, Science 272, 830 (1996); S. Tan, Y. Hunziker, D. F. Sargent, T. J. Richmond, Nature 381, 127 (1996).
6. D. B. Nikolov et al., Nature 377, 119 (1995); J. H. Geiger, S. Hahn, S. Lee, P. B. Sigler, Science 272, 830 (1996); S. Tan, Y. Hunziker, D. F. Sargent, T. J. Richmond, Nature 381, 127 (1996).
7. B. P. Cormack and K. Struhl, Cell 69, 685 (1992).
8. L. Kuras and K. Struhl, Nature 389, 609 (1999).
9. X.-L. Li, A. Virbasius, X. Zhu, M. R. Green, Nature 389, 605 (1999).
10. C. P. Verrijzer, K. Yokomori, J.-L. Chen, R. Tjian, Science 264, 933 (1994); C. P. Verrijzer, J. L. Chen, K. Yokomori, R. Tjian, Cell 81, 1115 (1995); T. Oelgeschlager, C. M. Chiang, R. G. Roeder, Nature 382, 735 (1996); T. W. Burke and J. T. Kadonaga, Genes Dev. 11, 3020 (1997).
11. C. P. Verrijzer, K. Yokomori, J.-L. Chen, R. Tjian, Science 264, 933 (1994); C. P. Verrijzer, J. L. Chen, K. Yokomori, R. Tjian, Cell 81, 1115 (1995); T. Oelgeschlager, C. M. Chiang, R. G. Roeder, Nature 382, 735 (1996); T. W. Burke and J. T. Kadonaga, Genes Dev. 11, 3020 (1997).
12. C. P. Verrijzer, K. Yokomori, J.-L. Chen, R. Tjian, Science 264, 933 (1994); C. P. Verrijzer, J. L. Chen, K. Yokomori, R. Tjian, Cell 81, 1115 (1995); T. Oelgeschlager, C. M. Chiang, R. G. Roeder, Nature 382, 735 (1996); T. W. Burke and J. T. Kadonaga, Genes Dev. 11, 3020 (1997).
13. C. P. Verrijzer, K. Yokomori, J.-L. Chen, R. Tjian, Science 264, 933 (1994); C. P. Verrijzer, J. L. Chen, K. Yokomori, R. Tjian, Cell 81, 1115 (1995); T. Oelgeschlager, C. M. Chiang, R. G. Roeder, Nature 382, 735 (1996); T. W. Burke and J. T. Kadonaga, Genes Dev. 11, 3020 (1997).
14. P. A. Grant et al., Cell 94, 45 (1998); V. V. Ogryzko et al., Cell 94, 35 (1998).
15. P. A. Grant et al., Cell 94, 45 (1998); V. V. Ogryzko et al., Cell 94, 35 (1998).
16. Z. Moqtaderi, Y. Bai, D. Poon, P. A. Weil, K. Struhl, Nature 362, 188 (1996).
17. S. S. Walker, J. C. Reese, L. M. Apone, M. R. Green, Nature 382, 185 (1996).
18. W. C. Shen and M. R. Green, Cell 90, 615 (1997).
19. S. S. Walker, W. C. Shen, J. C. Reese, L. M. Apone, M. R. Green, Cell 90, 607 (1997).
20. Z. Moqtaderi, M. Keaveney, K. Struhl, Mol. Cell 2, 675 (1998).
21. P. B. Komarnitsky, B. Michel, S. Buratowski, Genes Dev. 13, 2484 (1999). Two explanations (not mutually exclusive) could account for why the broad transcriptional effects reported to occur upon inactivation of the TAF40 temperature-sensitive mutant are indirect. First, the pre-heat shock protocol might irreversibly inactivate the TAF40 mutant before initiating the time course. Second, TAF40 mutant cells grown continuously at permissive temperature are likely to have altered physiology and gene regulatory patterns because of indirect effects of the mutant protein; the combination of such indirect effects with inactivation of the TAF40 derivative might be required for the broad transcriptional effects.
22. L. M. Apone et al., Mol. Cell 2, 653 (1998); B. Michel, P. Komarnitsky, S. Buratowski, Mol. Cell 2, 663 (1998); S. L. Sanders, E. R. Klebanow, P. A. Weil, J. Biol. Chem. 274, 18847 (1999).
23. L. M. Apone et al., Mol. Cell 2, 653 (1998); B. Michel, P. Komarnitsky, S. Buratowski, Mol. Cell 2, 663 (1998); S. L. Sanders, E. R. Klebanow, P. A. Weil, J. Biol. Chem. 274, 18847 (1999).
24. L. M. Apone et al., Mol. Cell 2, 653 (1998); B. Michel, P. Komarnitsky, S. Buratowski, Mol. Cell 2, 663 (1998); S. L. Sanders, E. R. Klebanow, P. A. Weil, J. Biol. Chem. 274, 18847 (1999).
25. We generated isogenic yeast strains in which the genes encoding these TAFs were replaced by epitope-tagged versions containing three copies of the HA-1 epitope and performed chromatin immunoprecipitation and quantitative analysis (4). For all four TAFs tested, we observed occupancy of various Pol II promoters in strains containing epitope-tagged TAFs but not in control cells containing untagged TAFs. TAFs were not associated with a tRNA gene promoter, which is transcribed by Pol III, or with a centrally located segment of the POL1 structural gene. When compared on the RPL9A promoter, crosslinking efficiencies of the various TAFs were about the same (0.2% to 0.4%). TBP occupancy on the same samples was determined by immunoprecipitation with TBP antibodies.
26. F. C. Holstege et al., Cell 95, 717 (1998).
27. X.-Y. Li, S. R. Bhaumik, M. R. Green, Science 288, 1242 (2000).
28. For ribosomal protein gene promoters, the TAF/TBP occupancy ratio is defined on nonshocked cells, because heat shock dramatically decreases transcription (24) and TBP occupancy. However, even under heat shock conditions, the residual transcription is associated with a TAF/TBP ratio of 1.
29. In accord with this suggestion, heat shock causes a Gcn5-dependent increase in histone H3 acetylation at a variety of inducible promoters (E. vomBaur, J. Deckert, K. Struhl, unpublished observations).
30. A. Hecht, S. Strahl-Bolsinger, M. Grunstein, Nature 383, 92 (1996); S. Strahl-Bolsinger, A. Hecht, K. Luo, M. Grunstein, Genes Dev. 11, 83 (1997);
31. A. Hecht, S. Strahl-Bolsinger, M. Grunstein, Nature 383, 92 (1996); S. Strahl-Bolsinger, A. Hecht, K. Luo, M. Grunstein, Genes Dev. 11, 83 (1997);
32. M. P. Cosma, T. Tanaka, K. Nasmyth, Cell 97, 299 (1999);
33. D. Dimova, Z. Nackerdien, S. Furgeson, S. Eguchi, M. A. Osley, Mol. Cell 4, 75 (1999).
34. Theoretically, all promoters that interact exclusively with TFIID should have the maximal TAF/TBP occupancy ratio. The ratio of 1.0 used here is arbitrarily defined, and it represents the maximal TAF/TBP occupancy ratio observed in a variety of promoters. It seems likely that promoters with a ratio of 1.0 interact exclusively with TFIID, although we cannot exclude the possibility that other promoters have higher TAF/TBP occupancy ratios.
35. D. E. Sterner et al., Mol. Cell. Biol. 19, 86 (1999).
36. S. K. Hansen, S. Takada, R. H. Jacobson, J. T. Lis, R. Tjian, Cell 91, 71 (1997).
37. B. Li, C. R. Nierras, J. R. Warner, Mol. Cell. Biol. 19, 5393 (1999).
38. Supported by grants from the Human Frontiers Science Program (L.K. and M.M), the Damon Runyon-Walter Winchell Cancer Research Foundation (P.K.), and NIH grant GM30186 (K.S.). We thank Z. Moqtaderi for fruitful discussions and comments on the manuscript and D. Gewirth for TFIIA and TFIIB used to make antibodies.